Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Protalix Biotherapeutics (PLX)
NYSE MKT:PLX
Protalix (PLX) Ownership - Who Owns Protalix?
727 Followers
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Oct 20, 2023 | Dror Bashan President & Ceo,director | xxxxxxxxxxxxx | $90484 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 24,112,510 | Insider | 32.89% | 26,523,761 | |
| 718,329 | Institution | 0.98% | 790,162 | |
| 673,754 | Insider | 0.92% | 741,129 | |
| 502,038 | Institution | 0.68% | 552,242 | |
| 291,431 | Institution | 0.40% | 320,574 | |
| 195,000 | Insider | 0.27% | 214,500 | |
| 185,000 | Insider | 0.25% | 203,500 | |
| 180,000 | Institution | 0.25% | 198,000 | |
| 159,132 | Institution | 0.22% | 175,045 | |
| 153,561 | Institution | 0.21% | 168,917 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 718,329 | Institution | 0.98% | 790,162 | |
| 502,038 | Institution | 0.68% | 552,242 | |
| 291,431 | Institution | 0.40% | 320,574 | |
| 180,000 | Institution | 0.25% | 198,000 | |
| 153,561 | Institution | 0.21% | 168,917 | |
| 120,000 | Institution | 0.16% | 132,000 | |
| 41,293 | Institution | 0.06% | 45,422 | |
| 30,000 | Institution | 0.04% | 33,000 | |
| 27,657 | Institution | 0.04% | 30,423 | |
| 27,400 | Institution | 0.04% | 30,140 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 159,132 | Institution | 0.22% | 175,045 | |
| 50,717 | Institution | 0.07% | 59,339 |
FAQ
Who Owns Protalix Biotherapeutics (PLX)?
Currently, no data Available
What percentage of Protalix Biotherapeutics (PLX) stock is held by institutional investors?
Currently, no data Available
What percentage of Protalix Biotherapeutics (PLX) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Protalix Biotherapeutics (PLX)?
Camber Capital Management LLC owns the most shares of Protalix Biotherapeutics (PLX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.